Articles of Interest - Neuroendocrine Tumors (NET)

2023

Status of Surveillance and Nonsurgical Therapy for Small Nonfunctioning Pancreatic Neuroendocrine Tumors.van Beek DJ, Verschuur AVD, Brosens LAA, Valk GD, Pieterman CRC, Vriens MR. Surg Oncol Clin N Am. 2023 Apr;32(2):343-371. PMID: 36925190 https://pubmed.ncbi.nlm.nih.gov/36925190/

Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?Ramamoorthy B, Nilubol N. Surg Oncol Clin N Am. 2023 Apr;32(2):315-325. PMID: 36925188 https://pubmed.ncbi.nlm.nih.gov/36925188/

Comparison of EUS-guided ablation and surgical resection for nonfunctioning small pancreatic neuroendocrine tumors: a propensity score-matching study.So H, Ko SW, Shin SH, Kim EH, Son J, Ha S, Song KB, Kim HJ. Gastrointest Endosc. 2023 Apr;97(4):741-751.e1. PMID: 36400239 https://pubmed.ncbi.nlm.nih.gov/36400239/

Status of Surveillance and Nonsurgical Therapy for Small Nonfunctioning Pancreatic Neuroendocrine Tumors.van Beek DJ, Verschuur AVD, Brosens LAA, Valk GD, Pieterman CRC, Vriens MR. Surg Oncol Clin N Am. 2023 Apr;32(2):343-371. PMID: 36925190 https://pubmed.ncbi.nlm.nih.gov/36925190/

Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?Ramamoorthy B, Nilubol N. Surg Oncol Clin N Am. 2023 Apr;32(2):315-325. PMID: 36925188 https://pubmed.ncbi.nlm.nih.gov/36925188/

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma.Sorbye H, Grande E, Pavel M, Tesselaar M, J Neuroendocrinol. 2023 Mar 1:e13249. PMID: 36924180 https://pubmed.ncbi.nlm.nih.gov/36924180/

Pancreatic Neuroendocrine Neoplasms Larger than 4 cm: A Retrospective Observational Study of Surgery, Histology, and Outcome.Milanetto AC, Gais Zürcher AL, David A, Fassan M, Pasquali C. J Clin Med. 2023 Feb 25;12(5):1840. PMID: 36902627 https://pubmed.ncbi.nlm.nih.gov/36902627/

Clinical Prediction Models for Recurrence in Patients with Resectable Grade 1 and 2 Sporadic Non-Functional Pancreatic Neuroendocrine Tumors: A Systematic Review.Chen JW, Heidsma CM, Engelsman AF, Kabaktepe E. Cancers (Basel). 2023 Feb 28;15(5):1525. PMID: 36900316 https://pubmed.ncbi.nlm.nih.gov/36900316/

Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future.La Rosa S. Endocr Pathol. 2023 Mar;34(1):79-97. PMID: 36797453 https://pubmed.ncbi.nlm.nih.gov/36797453/

Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort.Papantoniou D, Grönberg M, Thiis-Evensen E, Sorbye H, Landerholm K, Welin S, Tiensuu Janson E. Endocr Relat Cancer. 2023 Jan 1:ERC-22-0316. PMID: 36629395 https://pubmed.ncbi.nlm.nih.gov/36629395/

2022

Patients with non-functional metastatic G2 pancreatic neuroendocrine tumor benefit from palliative surgery: A 20-year single-center retrospective analysis.You T, Tang H, Xu X, Ying H, Sun Z, Cheng Y, Bai C. J Neuroendocrinol. 2022 Dec;34(12):e13211. PMID: 36373196 https://pubmed.ncbi.nlm.nih.gov/36373196/

Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors.Schiavo Lena M, Partelli S, Andreasi V, Muffatti F, Redegalli M, Brunetto E, Endocr Pathol. 2022 Dec 24. PMID: 36564582 https://pubmed.ncbi.nlm.nih.gov/36564582/

ASO Visual Abstract: Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms-A Systematic Review and Meta-Analysis.Ziogas IA, Tasoudis PT, Borbon LC, Sherman SK, Breheny PJ, Chandrasekharan C, Dillon JS, Bellizzi AM, Howe JR. Ann Surg Oncol. 2023 Jan;30(1):163-164. PMID: 36380256 https://pubmed.ncbi.nlm.nih.gov/36380256/

Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis.Ziogas IA, Tasoudis PT, Borbon LC, Sherman SK, Breheny PJ, Chandrasekharan C, Dillon JS, Bellizzi AM, Howe JR. Ann Surg Oncol. 2023 Jan;30(1):148-160. PMID: 36227392 https://pubmed.ncbi.nlm.nih.gov/36227392/

A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter study. Javed AA, Pulvirenti A, Zheng J, Michelakos T, Sekigami Y, Razi S, McIntyre CA, Thompson E, Klimstra DS, Deshpande V, Singhi AD, Weiss MJ, Wolfgang CL, Cameron JL, Wei AC, Zureikat AH, Ferrone CR, He J; Pancreatic Neuroendocrine Disease Alliance (PANDA). Surgery. 2022 Dec;172(6):1800-1806.PMID: 36192215 https://pubmed.ncbi.nlm.nih.gov/36192215/

Predictors of post-operative pancreatic fistula formation in pancreatic neuroendocrine tumors: A national surgical quality improvement program analysis.Hedges EA, Khan TM, Babic B, Nilubol N.Am J Surg. 2022 Nov;224(5):1256-1261. PMID: 35999087 https://pubmed.ncbi.nlm.nih.gov/35999087/

Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence-free survival.Daskalakis K, Wedin M, Tsoli M, Kogut A, Srirajaskanthan R, Sarras K, Kattiparambil S, Giovos G, Weickert MO, Kos-Kudla B, Kaltsas G.J Neuroendocrinol. 2022 Oct 8:e13205.PMID: 36385444 https://pubmed.ncbi.nlm.nih.gov/36385444/

Management and outcome of high-risk neuroendocrine tumors of the appendix in children; A systematic review.van Amstel P, Mahieu A, Bakx R, de Vries R, Raphael MF, Derikx JPM, van Heurn LWE, Gorter RR.Eur J Surg Oncol. 2022 Nov 9:S0748-7983(22)00713-2. PMID: 36372617https://pubmed.ncbi.nlm.nih.gov/36372617/

Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis. Ziogas IA, Tasoudis PT, Borbon LC, Sherman SK, Breheny PJ, Chandrasekharan C, Dillon JS, Bellizzi AM, Howe JR. Ann Surg Oncol. 2022 Oct 13. PMID: 36227392 https://pubmed.ncbi.nlm.nih.gov/36227392/

ASO Author Reflections: Surgical Resection Should be Considered in the Multidisciplinary Care of Patients with Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms. Ziogas IA, Dillon JS, Chandrasekharan C, Howe JR. Ann Surg Oncol. 2022 Oct 8. PMID: 36209329 https://pubmed.ncbi.nlm.nih.gov/36209329/

ASO Visual Abstract: Long-Term Outcomes of Patients with Multiple Endocrine Neoplasia Type 1 and Duodenopancreatic Neuroendocrine Neoplasms. Liu JB, Cai J, Dhir M, Paniccia A, Zureikat AH, Ramonell KM, McCoy KL, Carty SE, Yip L.Ann Surg Oncol. 2022 Nov;29(12):7818-7819. PMID: 36109415 https://pubmed.ncbi.nlm.nih.gov/36109415/

The management of small nonfunctional pancreatic neuroendocrine tumors: It's time to define the high-risk features. Tan Q, Chengzhi X, Chen Y. J Surg Oncol. 2022 Nov;126(6):1135-1136. PMID: 36004442 https://pubmed.ncbi.nlm.nih.gov/36004442/

Assessing Outcomes After Adrenalectomy for Primary Aldosteronism - Early is Accurate: Retrospective Cohort Study. Suurd DPD, Vorselaars WMCM, Van Beek DJ, Borel Rinkes IHM, Spiering W, Valk GD, Vriens MR. Ann Surg. 2022 Nov 1;276(5):929-934. PMID: 35894426 https://pubmed.ncbi.nlm.nih.gov/35894426/

Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers. Levy S, Arthur JD, Banks M, Kok NFM, Fenwick SW, Diaz-Nieto R, van Leerdam ME, Cuthbertson DJ, Valk GD, Kuhlmann KFD, Tesselaar MET .Ann Surg Oncol. 2022 Nov;29(12):7822-7832. PMID: 35842528 https://pubmed.ncbi.nlm.nih.gov/35842528/

Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). Battistella A, Partelli S, Andreasi V, Marinoni I, Palumbo D, Tacelli M, Lena MS, Muffatti F, Mushtaq J, Capurso G, Arcidiacono PG, De Cobelli F, Doglioni C, Perren A, Falconi M.Surgery. 2022 Oct;172(4):1236-1244. PMID: 35953308 https://pubmed.ncbi.nlm.nih.gov/35953308/

Sequencing of Therapies in Progressive Neuroendocrine Tumors.Howe JR.Ann Surg O col. 2022 Oct;29(11):6501-6503. PMID: 35816247 https://pubmed.ncbi.nlm.nih.gov/35816247/

Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms? Borbon LC, Tran CG, Sherman SK, Ear PH, Chandrasekharan C, Bellizzi AM, Dillon JS, O'Dorisio TM, Howe JR. Ann Surg Oncol. 2022 Oct;29(11):6936-6946.PMID: 35802214 https://pubmed.ncbi.nlm.nih.gov/35802214/

ASO Visual Abstract: Long-Term Outcomes of Patients with Multiple Endocrine Neoplasia Type 1 and Duodenopancreatic Neuroendocrine Neoplasms. Liu JB, Cai J, Dhir M, Paniccia A, Zureikat AH, Ramonell KM, McCoy KL, Carty SE, Yip L. Ann Surg Oncol. 2022 Sep 15. PMID: 36109415 https://pubmed.ncbi.nlm.nih.gov/36109415

Endoscopic ultrasound-guided radiofrequency ablation for nonfunctional pancreatic neuroendocrine tumors: Put the gun away or keep shooting? Rimbaș M, Tripodi G, Larghi A.Dig Endosc. 2022 Sep;34(6):1257. PMID: 35545866 https://pubmed.ncbi.nlm.nih.gov/35545866/

Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies. Ruggeri RM, Benevento E, De Cicco F, Fazzalari B, Guadagno E, Hasballa I, Tarsitano MG, Isidori AM, Colao A, Faggiano A; NIKE Group.J Endocrinol Invest. 2022 Aug 30. PMID: 36038743 https://pubmed.ncbi.nlm.nih.gov/36038743/

Predictors of post-operative pancreatic fistula formation in pancreatic neuroendocrine tumors: A national surgical quality improvement program analysis. Hedges EA, Khan TM, Babic B, Nilubol N.Am J Surg. 2022 Aug 10:S0002-9610(22)00452-4. PMID: 35999087 https://pubmed.ncbi.nlm.nih.gov/35999087/

Long-Term Outcomes for Patients with Multiple Endocrine Neoplasia Type 1 and Duodenopancreatic Neuroendocrine Neoplasms. Liu JB, Cai J, Dhir M, Paniccia A, Zureikat AH, Ramonell KM, McCoy KL, Carty SE, Yip L.Ann Surg Oncol. 2022 Aug 13. PMID: 35963905  https://pubmed.ncbi.nlm.nih.gov/35963905/

Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study. Perinel J, Nappo G, Zerbi A, Heidsma CM, Nieveen van Dijkum EJM, Han HS, Yoon YS, Satoi S, Demir IE, Friess H, Vashist Y, Izbicki J, Muller AC, Gloor B, Sandini M, Gianotti L, Subtil F, Adham M.Surgery. 2022 Sep;172(3):975-981. PMID: 35623953  https://pubmed.ncbi.nlm.nih.gov/35623953/

Tuberous sclerosis complex-associated nonfunctional pancreatic neuroendocrine tumors: Management and surgical outcomes. Evans LM, Geenen KR, O'Shea A, Hedgire SS, Ferrone CR, Thiele EA.Am J Med Genet A. 2022 Sep;188(9):2666-2671. PMID: 35612824 https://pubmed.ncbi.nlm.nih.gov/35612824/

The utility of near infrared autofluorescence imaging for detecting small bowel carcinoid tumors in comparison to DOTATATE PET: A pilot study. Berber E, Ergun O, Avci S, Isiktas G, Osman M, Mahajan P.J Surg Oncol. 2022 Aug 12. PMID: 35960603 https://pubmed.ncbi.nlm.nih.gov/35960603

Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study. Yang Z, Zhang D, Shi G.Front Endocrinol (Lausanne). 2022 Jul 18;13:928341: 35923628  https://pubmed.ncbi.nlm.nih.gov/35923628/

Continuing challenges of primary neuroendocrine tumours of the thymus: A concisereview. Lau J, Ioan Cvasciuc T, Simpson D, C de Jong M, Parameswaran R.Eur J Surg Oncol. 2022 Jul 22:S0748-7983(22)00559-5. PMID: 35922282 https://pubmed.ncbi.nlm.nih.gov/35922282/

ASO Visual Abstract: Primary Tumour Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumours (NET)-A Comparison of Upfront Surgical Resection versus a Watch-and-Wait Strategy in Two Specialist NET Centres.Levy S, Arthur JD, Banks M, Kok NFM, Fenwick SW, Diaz-Nieto R, van Leerdam ME, Cuthbertson DJ, Valk GD, Kuhlmann KFD, Tesselaar MET.Ann Surg Oncol. 2022 Jul 29. PMID: 35906323  https://pubmed.ncbi.nlm.nih.gov/35906323/

Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter. Exarchou K, Hu H, Stephens NA, Moore AR, Kelly M, Lamarca A, Mansoor W, Hubner R, McNamara MG, Smart H, Howes NR, Valle JW, Pritchard DM.Endocrine. 2022 Jul 27. PMID: 35895180 https://pubmed.ncbi.nlm.nih.gov/35895180/ 

Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study.Tan Q, Wang X, Li Y, Liu Y, Liu X, Ke N.Front Endocrinol (Lausanne). 2022 Jul 6;13:907415. PMID: 35873006 https://pubmed.ncbi.nlm.nih.gov/35873006/

Hyperglycemia is associated with adverse prognosis in patients with pancreatic neuroendocrine neoplasms.Zhang P, Xiao Z, Xu H, Zhu X, Wang L, Huang D, Liang Y, Ni Q, Chen J, Yu X, Luo G.Endocrine. 2022 Aug;77(2):262-271. PMID: 35790660 https://pubmed.ncbi.nlm.nih.gov/35790660/

ASO Visual Abstract: Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms? Borbon LC, Tran CG, Sherman SK, Ear PH, Chandrasekharan C, Bellizzi AM, Dillon JS, O'Dorisio TM, HoweJR. Ann Surg Oncol. 2022Jul, 18. PMID:  35849292  https://pubmed.ncbi.nlm.nih.gov/35849292/ 

Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers. Levy S, Arthur JD, Banks M, Kok NFM, Fenwick SW, Diaz-Nieto R, van Leerdam ME, Cuthbertson DJ, Valk GD, Kuhlmann KFD, Tesselaar MET.Ann Surg Oncol. 2022 Jul 16. PMID: 35842528  https://pubmed.ncbi.nlm.nih.gov/35842528/

Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors. Thiis-Evensen E, Kjellman M, Knigge U, Gronbaek H, Schalin-Jäntti C, Welin S, Sorbye H, Del Pilar Schneider M, Belusa R; Nordic NET Biomarker Group.J Neuroendocrinol. 2022 Jun 14:e13176. PMID: 35829662  https://pubmed.ncbi.nlm.nih.gov/35829662/ 

Sequencing of Therapies in Progressive Neuroendocrine Tumors. Howe JR.Ann Surg Oncol. 2022 Jul 11. PMID: 35816247  https://pubmed.ncbi.nlm.nih.gov/35816247/

Hyperglycemia is associated with adverse prognosis in patients with pancreatic neuroendocrine neoplasms. Zhang P, Xiao Z, Xu H, Zhu X, Wang L, Huang D, Liang Y, Ni Q, Chen J, Yu X, Luo G.Endocrine. 2022 Jul 5. PMID: 35790660 https://pubmed.ncbi.nlm.nih.gov/35790660/

Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?Borbon LC, Tran CG, Sherman SK, Ear PH, Chandrasekharan C, Bellizzi AM, Dillon JS, O'Dorisio TM, Howe JR.Ann Surg Oncol. 2022 Jul 8. PMID: 35802214  https://pubmed.ncbi.nlm.nih.gov/35802214/

Clinical Features of Pancreatic Neuroendocrine Microadenoma: A Single-Center Experience and Literature Review. Okawa Y, Tsuchikawa T, Hatanaka KC, Matsui A, Tanaka K, Nakanishi Y, Asano T, Noji T, Nakamura T, Mitsuhashi T, Okamura K, Hatanaka Y, Hirano S.Pancreas. 2022 Apr 1;51(4):338-344. PMID: 35699685  https://pubmed.ncbi.nlm.nih.gov/35699685/

ASO Visual Abstract: Management of Small Bowel Neuroendocrine Tumors. Tran CG, Sherman SK, Howe JR.Ann Surg Oncol. 2021 May;28(5):2754-2755 PMID: 35755138  https://pubmed.ncbi.nlm.nih.gov/35755138/

Comparison Between Sporadic and Multiple Endocrine Neoplasia Type 1-Associated Insulinoma. Sada A, Habermann EB, Szabo Yamashita T, Thompson GB, Lyden ML, Foster TR, Dy BM, Halfdanarsond TR, Vella A, McKenzie TJ.J Am Coll Surg. 2022 Jun 24. PMID: 35752874  https://pubmed.ncbi.nlm.nih.gov/35752874/

Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Dai M, Mullins CS, Lu L, Alsfasser G, Linnebacher M.World J Gastrointest Surg. 2022 May 27;14(5):383-396.: 35734622 https://pubmed.ncbi.nlm.nih.gov/35734622/

Clinical Features of Pancreatic Neuroendocrine Microadenoma: A Single-Center Experience and Literature Review. Okawa Y, Tsuchikawa T, Hatanaka KC, Matsui A, Tanaka K, Nakanishi Y, Asano T, Noji T, Nakamura T, Mitsuhashi T, Okamura K, Hatanaka Y, Hirano S.Pancreas. 2022 Jun 15. PMID: 35699685 https://pubmed.ncbi.nlm.nih.gov/35699685/

Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China. Zhao Y, Yu J, Liu Y, Lyu L, Ping F, Xu L, Li W, Wang O, Xu Q, Wu W, Zhang H, Li Y.Orphanet J Rare Dis. 2022 Jun 13;17(1):219. PMID: 35698198 https://pubmed.ncbi.nlm.nih.gov/35698198/

Natural History of Pancreatic Duct Obstruction by a Pancreatic Neuroendocrine Tumor. Thomas AS, Luk L, Chabot JA.J Gastrointest Surg. 2022 Jun;26(6):1340-1341. PMID: 35083721 https://pubmed.ncbi.nlm.nih.gov/35083721/

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy. Muñoz de Nova JL, Hernando J, Sampedro Núñez M, Vázquez Benítez GT, Triviño Ibáñez EM, Del Olmo García MI, Barriuso J, Capdevila J, Martín-Pérez E.World J Gastroenterol. 2022 Apr 7;28(13):1304-1314. PMID: 35645544 https://pubmed.ncbi.nlm.nih.gov/35645544/

New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.  Yin F, Wu ZH, Lai JP. World J Gastroenterol. 2022 May 7;28(17):1751-1767. doi: 10.3748/wjg.v28.i17.1751. PMID: 35633912 https://pubmed.ncbi.nlm.nih.gov/35633912/

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy. Muñoz de Nova JL, Hernando J, Sampedro Núñez M, Vázquez Benítez GT, Triviño Ibáñez EM, Del Olmo García MI, Barriuso J, Capdevila J, Martín-Pérez E. World J Gastroenterol. 2022 Apr 7;28(13):1304-1314. PMID: 35645544 https://pubmed.ncbi.nlm.nih.gov/35645544/

Intraoperative Ultrasound Guided Laparoscopic Spleen-Preserving Distal Pancreatectomy for Primitive Neuroendocrine Tumors in a Pediatric Patient with MEN-1. McKay KG, Hanna DN, Martin L, Datye KA, Crane GL, Correa H, Lovvorn HN 3rd, Solorzano CC, Zamora IJ. Am Surg. 2022 Apr 26:31348221093802. PMID: 35471864 https://pubmed.ncbi.nlm.nih.gov/35471864/

Laparoscopic Enucleation of Pancreatic Neoplasms: A Single-Center Experience and Outcomes. Bruballa R, Fratantoni ME, Ardiles V, Mazza O. J Laparoendosc Adv Surg Tech A. 2022 Apr 19.. PMID: 35446126 https://pubmed.ncbi.nlm.nih.gov/35446126/

Validated Risk-Score Model Predicting Lymph Node Metastases in Patients with Non-Functional Gastroenteropancreatic Neuroendocrine Tumors. Shannon AB, Straker RJ 3rd, Fraker DL, Miura JT, Karakousis GC. J Am Coll Surg. 2022 May 1;234(5):900-909. PMID: 35426404  https://pubmed.ncbi.nlm.nih.gov/35426404/

Validated Risk-Score Model Predicting Lymph Node Metastases in Patients with Non-Functional Gastroenteropancreatic Neuroendocrine Tumors. Shannon AB, Straker RJ 3rd, Fraker DL, Miura JT, Karakousis GC.J Am Coll Surg. 2022 May 1. PMID: 35426404 https://pubmed.ncbi.nlm.nih.gov/35426404/

Long-term survival of metastatic small intestine neuroendocrine tumors: a meta-analysis. Van Den Heede K, Chidambaram S, Van Slycke S, Brusselaers N, Warfvinge CF, Ohlsson H, Gustafsson R, Nordenström E, Almquist M. Endocr Relat Cancer. 2022 Feb 7;29(3):163-173. PMID: 34982042 https://pubmed.ncbi.nlm.nih.gov/34982042/

Risk factors for complications after surgery for pancreatic neuroendocrine tumors. van Beek DJ, Takkenkamp TJ, Wong-Lun-Hing EM, de Kleine RHJ, Walenkamp AME, Klaase JM, Nijkamp MW, Valk GD, Molenaar IQ, Hagendoorn J, van Santvoort HC, Borel Rinkes IHM, Hoogwater FJH, Vriens MR. Surgery. 2022 Mar 24:S0039-6060(22)00086-1. PMID: 35341591 https://pubmed.ncbi.nlm.nih.gov/35341591/

Observation Versus Resection for Small, Localized, and Nonfunctional Pancreatic Neuroendocrine Tumors: A Propensity Score Matching Study. Zhu J, Fu C, Zhang Y, Zhou X, Xiao W, Li Y. Pancreas. 2022 Jan 1;51(1):56-62. PMID: 35195596 https://pubmed.ncbi.nlm.nih.gov/35195596/

2021

Prognostic value of whole-body PET volumetric parameters extracted from 68 Ga-DOTATOC-PET/CT in well-differentiated neuroendocrine tumors. https://pubmed.ncbi.nlm.nih.gov/34740949/
Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine. Elias E, Ardalan A, Lindberg M, Reinsbach SE, Muth A, Nilsson O, Arvidsson Y, Larsson E. Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine. Nat Commun. 2021 Nov 4;12(1):6367. doi: 10.1038/s41467-021-26581-5. PMID: 34737276. https://pubmed.ncbi.nlm.nih.gov/34737276/

Management recommendations for pancreatic manifestations of von Hippel-Lindau disease. Laks S, van Leeuwaarde R, Patel D, Keutgen XM, Hammel P, Nilubol N, Links TP, Halfdanarson TR, Daniels AB, Tirosh A; Pancreatic Manifestations Recommendations Development Subcommittee of the VHL Alliance. Management recommendations for pancreatic manifestations of von Hippel-Lindau disease. Cancer. 2021 Nov 4. doi: 10.1002/cncr.33978. Epub ahead of print. PMID: 34735022. https://pubmed.ncbi.nlm.nih.gov/34735022/

Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms? Exarchou K, Kamieniarz L, Tsoli M, Victor A, Oleinikov K, Khan MS, Srirajaskanthan R, Mandair D, Grozinsky-Glasberg S, Kaltsas G, Howes N, Pritchard DM, Toumpanakis C. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms? Endocrine. 2021 Nov;74(2):421-429. doi: 10.1007/s12020-021-02775-1. Epub 2021 Jun 12. PMID: 34120313. https://pubmed.ncbi.nlm.nih.gov/34120313/